DeepMed Research

FRED HUTCHINSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: https://www.fredhutch.org

Clinical Trials

CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

Phase 2

Terminated

Conditions: Acute Myeloid Leukemia
Myelodysplastic Syndrome With Excess Blasts-2
Myeloid Neoplasm

Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Drug: Liposome-encapsulated Daunorubicin-Cytarabine

First Posted Date: 2020-08-25

Last Posted Date: 2024-05-23

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 1

Registration Number: NCT04526288

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation

Phase 1

Completed

Conditions: Cigarette Smoking-Related Carcinoma

Interventions: Other: Health Promotion and Education
Behavioral: Smoking Cessation Intervention (Actify app)
Behavioral: Smoking Cessation Intervention (Current Standard Care app)
Other: Survey Administration

First Posted Date: 2020-08-25

Last Posted Date: 2024-03-07

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 242

Registration Number: NCT04525222

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Not Applicable

Recruiting

Conditions: Malignant Solid Neoplasm

Interventions: Other: Internet-Based Intervention
Other: Best Practice
Other: Questionnaire Administration

First Posted Date: 2020-08-17

Last Posted Date: 2025-03-06

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 400

Registration Number: NCT04515810

Locations: 🇺🇸
Northwell Health, Manhasset, New York, United States
🇺🇸
Mount Sinai Hospital, New York, New York, United States
🇺🇸
NYP/Weill Cornell Medical Center, New York, New York, United States

and more 1 locations

SmartQuit Program for Smoking Cessation

Not Applicable

Completed

Conditions: Tobacco-Related Carcinoma
Cigarette Smoking-Related Carcinoma

Interventions: Behavioral: SmartQuit Smoking and Tobacco Cessation Program
Other: Survey Administration

First Posted Date: 2020-08-12

Last Posted Date: 2020-08-12

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 99

Registration Number: NCT04510077

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans

Phase 1

Completed

Conditions: Cigarette Smoking-Related Carcinoma

Interventions: Behavioral: Smoking Cessation Intervention (New website)
Behavioral: Smoking Cessation Intervention (Standard of care website)
Behavioral: Health Education
Other: Health Promotion and Education
Other: Questionnaire Administration

First Posted Date: 2020-08-06

Last Posted Date: 2023-04-07

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 53

Registration Number: NCT04502524

Locations: 🇺🇸
Bedford VA Research Corporation, Inc., Bedford, Massachusetts, United States

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Phase 2

Completed

Conditions: Recurrent Bladder Urothelial Carcinoma
Stage 0is Bladder Cancer AJCC v8
Bladder Urothelial Carcinoma In Situ
Stage 0a Bladder Cancer AJCC v8
Stage I Bladder Cancer AJCC v8
Superficial Bladder Urothelial Carcinoma

Interventions: Device: Acupuncture Therapy
Biological: BCG Solution
Other: Best Practice
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2020-08-03

Last Posted Date: 2024-01-02

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 45

Registration Number: NCT04496219

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

Phase 1

Withdrawn

Conditions: Plasma Cell Myeloma

Interventions: Biological: Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
Drug: Melphalan
Procedure: Peripheral Blood Stem Cell Transplantation

First Posted Date: 2020-07-10

Last Posted Date: 2024-01-31

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT04466475

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study

Phase 3

Active, not recruiting

Conditions: Obesity-Related Malignant Neoplasm

Interventions: Other: Survey Administration
Behavioral: Telephone-Based Intervention

First Posted Date: 2020-06-25

Last Posted Date: 2025-02-20

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 418

Registration Number: NCT04447313

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Cancer Communication Within Hispanic Social Networks

Not Applicable

Completed

Conditions: Colorectal Carcinoma

Interventions: Other: Media Intervention
Other: Survey Administration

First Posted Date: 2020-06-23

Last Posted Date: 2020-06-23

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 57

Registration Number: NCT04444232

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Recruiting

Conditions: Chronic Graft Versus Host Disease

Interventions: Procedure: Biospecimen Collection
Other: Medical Chart Review
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2020-06-16

Last Posted Date: 2025-05-02

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 200

Registration Number: NCT04431479

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
Dana-Farber Harvard Cancer Center, Boston, Massachusetts, United States

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy